Meropenem And Sodium Chloride Injection, Solution
Product Images NDC 0264-3185

9 FDA label images from B. Braun Medical Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Meropenem And Sodium Chloride (NDC 0264-3185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram 1 (Meropenem In Duplex 1)

Diagram 1 (Meropenem In Duplex 1)
An instructional diagram illustrating how to open or access a packaging tab labeled 'Side Tab.' The graphic shows a hand interacting with the tab, which is part of a product container or carton, likely related to the Meropenem and Sodium Chloride injection solution packaging.*
FDA Label Image

Diagram 2 (Meropenem In Duplex 2)

Diagram 2 (Meropenem In Duplex 2)
An instructional diagram of the Meropenem and Sodium Chloride intravenous injection system. It labels the Diluent Chamber, Drug Powder Chamber with a peelable Foil Strip, Hanger Tab, and a Set Port covered with a Foil Cover, illustrating the components and structure of the solution injection device.*
FDA Label Image

Diagram 3 (Meropenem In Duplex 3)

Diagram 3 (Meropenem In Duplex 3)
An instructional line drawing labeled Diagram 3 showing hands holding and handling an intravenous injection solution container with a spout at the bottom, illustrating part of the preparation or administration process for Meropenem and Sodium Chloride injection solution.*
FDA Label Image

Diagram 4 (Meropenem In Duplex 4)

Diagram 4 (Meropenem In Duplex 4)
An instructional illustration showing hands operating a component of an intravenous injection solution container. The image details the interaction with the container's closure or valve mechanism, likely pertaining to the preparation or administration process of Meropenem and Sodium Chloride injection solution.*
FDA Label Image

Diagram 5 (Meropenem In Duplex 5)

Diagram 5 (Meropenem In Duplex 5)
Illustrative diagram showing a simplified intravenous bag with a set port and foil cover labeled. The diagram likely depicts a component or part of the Meropenem and Sodium Chloride injection solution packaging or preparation device by B. Braun Medical Inc.*
FDA Label Image

Structural Formula (Meropenem In Duplex 6)

Structural Formula (Meropenem In Duplex 6)
Chemical structure of the active ingredient Meropenem shown with labeled atoms and functional groups, including a beta-lactam ring and side chains. The structure also indicates the presence of three water molecules (3H2O).*
FDA Label Image

500 mg 50ml Container Label (Meropenem In Duplex 7)

500 mg 50ml Container Label (Meropenem In Duplex 7)
Label for Meropenem and Sodium Chloride Injection USP 500 mg/50 mL intravenous solution, single-dose DUPLEX container by B. Braun Medical Inc. The label includes storage instructions, reconstitution directions, and product identification with lot and expiration date fields, and a barcode with NDC number.*
FDA Label Image

1g 50ml Container Label (Meropenem In Duplex 8)

1g 50ml Container Label (Meropenem In Duplex 8)
Label for Meropenem and Sodium Chloride Injection USP, 1g/50mL, a sterile intravenous injection solution. The single-dose DUPLEX container includes instructions for reconstitution and storage. Manufactured by B. Braun Medical Inc., prepared in Italy with API from Italy and Austria. Label contains warnings, storage conditions, and usage directions.*
FDA Label Image

Drug Chamber (Meropenem In Duplex 9)

Drug Chamber (Meropenem In Duplex 9)
A drug chamber label panel for Meropenem and Sodium Chloride injection solution. It instructs to discard the unit if the foil strip is damaged, to peel the foil strip only when ready for use, and to visually inspect the drug prior to reconstitution. It also advises consulting the package insert for complete directions on reconstitution and administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.